Status:

COMPLETED

Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability

Lead Sponsor:

RTI International

Collaborating Sponsors:

Womack Army Medical Center

Tripler Army Medical Center

Conditions:

Posttraumatic Stress Disorder

Eligibility:

All Genders

18+ years

Brief Summary

This qualitative study will use focus groups, small group interviews, and individual interviews (both in person and over the phone) to compile a range of perspectives on service members' decision-maki...

Detailed Description

The qualitative (acceptability) study will use focus groups, small group interviews, and individual interviews (both in person and telephonic) to compile a range of perspectives on service members' de...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Service members must have received at least one SGB and/or study procedure for PTSD symptoms during the past three months at a participating study site (as a participant in the clinical effectiveness trial or outside of the study).
  • Clinical trial participants must have indicated willingness to participate in the qualitative study when asked by the Research Coordinator (RC) at baseline data collection.
  • Non-clinical trial participants must be active-duty status.
  • A service member/spouse dyad will consist of a service member meeting an above criterion and his/her spouse.
  • Providers will be Behavioral Health or other (e.g., Family Medicine) clinicians who have referred or could potentially have referred service members to the study, and physicians who administer SGBs.
  • Exclusion Criteria:
  • • Service members will be excluded from the qualitative study if participation would cause them undue distress, in the opinion of the RC or treating clinician.

Exclusion

    Key Trial Info

    Start Date :

    November 3 2017

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 2 2018

    Estimated Enrollment :

    54 Patients enrolled

    Trial Details

    Trial ID

    NCT03302312

    Start Date

    November 3 2017

    End Date

    March 2 2018

    Last Update

    July 30 2018

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Tripler Army Medical Center (TAMC)

    Honolulu, Hawaii, United States, 96859

    2

    Womack Army Medical Center (WAMC)

    Fort Bragg, North Carolina, United States, 28310

    3

    Landstuhl Regional Medical Center (LRMC)

    Landstuhl, Germany, 66849